 |
MXene- New Family of 2-D Metal Carbides and Nitrides
PHILADELPHIA (August 22, 2011) – An urgent challenge currently faced by researchers and the public alike is the ability to identify the next generation of sustainable, cost-effective, and energy efficient materials for our everyday use. While searching for new materials for electrical energy storage, a team of Drexel University materials scientists has discovered a new family of two-dimensional compounds proposed to have unique properties that may lead to groundbreaking advances in energy storage technology.
|
|
|
|
Schematic of the exfoliated Ti3AlC2 forming two OH-terminated MXene layers |
Scanning electron micrograph of an exfoliated particle with the size of about 10 micrometers. MXenesheets can be separated by sonication. |
The research team led by Dr. Yury Gogotsi, Distinguished University Professor of Materials Science and Engineering and Director of the A.J. Drexel Nanotechnology Institute and Dr. Michel Barsoum, Grosvenor and Distinguished Professor of Materials Science and Engineering, has recently published a paper titled "Two-Dimensional Nanocrystals Produced by Exfoliation of Ti3AlC2," appearing in the highly prestigious journalAdvanced Materials. In their paper, the research team recounts their ability to transform three dimensional titanium-aluminum carbide, a typical representative of a family of layered ternary carbides called MAX phases, into a two dimensional structure with greatly different properties. MAX phases, known as ductile and machineable ceramics, have been researched by Prof. Barsoum’s lab for more than a decade and dozens of layered carbides, nitrides and carbonitrides with a variety of properties have been synthesized. However, these ceramics have always been produced as 3-dimensional materials.
Source: http://nano.materials.drexel.edu/
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
